Copyright
©The Author(s) 2005.
World J Gastroenterol. Aug 28, 2005; 11(32): 5064-5067
Published online Aug 28, 2005. doi: 10.3748/wjg.v11.i32.5064
Published online Aug 28, 2005. doi: 10.3748/wjg.v11.i32.5064
Hereditary causes | Acquired causes |
Resistance to APC = Factor V-Leiden | Antiphospholipid syndrome |
(Factor V gene mutation G1691A) | Lupus anticoagulant |
Prothrombin gene mutation | Malignancy and myeloproliferative |
(G20210A) | disorders |
Antithrombin III deficiency | Hyperviscosity (multiple myeloma) |
Hyperhomocysteinemia | Cardiac failure and any type of shock |
(MTHFR mutation) | |
Protein C deficiency | Nephrotic syndrome |
Protein S deficiency | Liver cirrhosis |
Dysfibrinogenemia | Protein-losing enteropathy |
Increased factor VIII and PAI-1 | Chronic inflammatory bowel disease |
Plasminogen deficiency | Hemolytic uremic syndrome |
tPA deficiency | Thrombotic thrombocytopenic purpura |
Post-surgery, post-traumatic, | |
immobilization | |
Oral contraceptives and smoking | |
Obesity | |
Pregnancy | |
Geriatric patients |
- Citation: Siewert E, Salzmann J, Purucker E, Schürmann K, Matern S. Recurrent thrombotic occlusion of a transjugular intrahepatic portosystemic stent-shunt due to activated protein C resistance. World J Gastroenterol 2005; 11(32): 5064-5067
- URL: https://www.wjgnet.com/1007-9327/full/v11/i32/5064.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i32.5064